GlassScriptPhysician profile
Edna I Flores
NPI 1396994604
$33,932.19
in general payments reported to CMS, 2019-2025
91 companies · $5,658 in 2025
The $5,658 reported for 2025 was more than what 75% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,486 · 2020: $5,085 · 2021: $3,790 · 2022: $2,773 · 2023: $6,858 · 2024: $6,282 · 2025: $5,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $2,299 · Consulting Fee: $1,910 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,563.64 |
| Long Term Medical Supply Or Device Loan | $2,299.02 |
| Consulting Fee | $1,910.00 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $8,252.48 | 2019-2025 | |
| Seagen INC. | $1,905.48 | 2019-2023 | Adcetris, Tivdak, Padcev |
| Astrazeneca Pharmaceuticals LP | $1,864.48 | 2019-2025 | Imfinzi, Tagrisso, Calquence |
| Daiichi Sankyo INC. | $1,597.26 | 2019-2025 | Enhertu, Injectafer |
| Epizyme, INC. | $1,336.17 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $1,317.55 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Puma Biotechnology, INC. | $1,289.13 | 2019-2025 | Nerlynx |
| Genzyme Corporation | $1,149.19 | 2019-2025 | |
| Celgene Corporation | $1,078.13 | 2019-2025 | Reblozyl, Pomalyst, Opdivo |
| Pfizer INC. | $1,017.25 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $991.38 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Amgen INC. | $909.67 | 2019-2023 | Kyprolis, Blincyto, Nplate |
| Gilead Sciences, INC. | $785.61 | 2019-2025 | Trodelvy |
| Alexion Pharmaceuticals, INC. | $709.86 | 2022-2025 | Ultomiris |
| Glaxosmithkline, LLC. | $646.03 | 2020-2025 | Zejula, Jemperli, Ojjaara |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $598.29 | 2019-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Janssen Biotech, INC. | $572.30 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Exelixis INC. | $442.12 | 2020-2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $421.85 | 2021-2025 | |
| Incyte Corporation | $392.48 | 2019-2025 | Jakafi, Monjuvi |
| Sobi, INC | $348.44 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $316.90 | 2019-2023 | Imbruvica, Epkinly |
| Regeneron Healthcare Solutions, INC. | $311.74 | 2020-2024 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $276.78 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Genentech USA, INC. | $272.43 | 2019-2025 | Itovebi, Phesgo, Tecentriq |
| Blueprint Medicines Corporation | $262.07 | 2020-2025 | Ayvakit |
| Emd Serono, INC. | $261.30 | 2019-2025 | Bavencio |
| Abbvie INC. | $259.51 | 2019-2025 | |
| Beigene USA, INC. | $247.08 | 2022-2024 | Brukinsa |
| Array Biopharma INC | $232.93 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Coherus Oncology, INC. | $232.25 | 2020-2025 | Loqtorzi, Udenyca |
| Eisai INC. | $229.33 | 2019-2025 | |
| Pharmaessentia USA Corporation | $226.09 | 2022-2025 | Besremi |
| Kite Pharma, INC. | $176.76 | 2021-2025 | Yescarta |
| Astellas Pharma US INC | $146.17 | 2019-2025 | Vyloy, Padcev, Xospata |
| Tersera Therapeutics LLC | $137.70 | 2019-2025 | Zoladex |
| Mirati Therapeutics, INC. | $136.18 | 2023-2024 | Krazati |
| Immunocore Limited | $130.13 | 2023-2024 | Kimmtrak |
| Genmab U.S., INC. | $127.51 | 2023-2025 | Epkinly |
| Menarini Silicon Biosystems, INC. | $126.35 | 2023 | Cellsearch |
| Taiho Oncology, INC. | $118.70 | 2023-2025 | |
| Lilly USA, LLC | $107.45 | 2020-2024 | Jaypirca, Retevmo, Verzenio |
| Rigel Pharmaceuticals, INC. | $104.05 | 2021-2023 | Rezlidhia, Tavalisse |
| Karyopharm Therapeutics INC. | $103.91 | 2022-2025 | Xpovio |
| Caris Mpi, INC. | $95.89 | 2025 | Mi Cancer Seek |
| Aveo Pharmaceuticals, INC. | $92.18 | 2023-2025 | Fotivda |
| Acrotech Biopharma INC. | $81.95 | 2022-2024 | Beleodaq |
| Geron Corporation | $81.09 | 2024-2025 | Rytelo |
| Stemline Therapeutics INC. | $78.25 | 2023-2024 | Orserdu |
| Eusa Pharma (US) LLC | $69.40 | 2019 | |
| Adc Therapeutics America, INC. | $68.10 | 2021-2023 | |
| Morphosys, US INC. | $66.91 | 2022-2023 | Monjuvi |
| Sun Pharmaceutical Industries INC. | $56.48 | 2019-2022 | |
| Iovance Biotherapeutics, INC. | $51.21 | 2025 | Amtagvi |
| Deciphera Pharmaceuticals INC. | $48.66 | 2020-2021 | |
| Foundation Medicine, INC. | $47.65 | 2019-2023 | |
| Servier Pharmaceuticals LLC | $44.91 | 2021-2022 | |
| Fennec Pharmaceuticals, INC. | $44.90 | 2024-2025 | Pedmark, Fyarro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.82 | 2019-2021 | |
| Octapharma USA, INC. | $42.11 | 2022-2024 | Panzyga |
| Accord Healthcare, INC. | $40.76 | 2023-2025 | |
| Tempus Ai, INC | $39.75 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $34.34 | 2019-2020 | |
| Clovis Oncology, INC. | $32.90 | 2019 | |
| Legend Biotech USA INC. | $32.82 | 2025 | Carvykti |
| Partner Therapeutics, INC. | $32.70 | 2019 | |
| Ge Healthcare | $32.04 | 2022 | |
| Syndax Pharmaceuticals, INC. | $29.57 | 2025 | |
| Agios Pharmaceuticals, INC. | $28.66 | 2025 | Pyrukynd |
| Cumberland Pharmaceuticals, INC. | $28.11 | 2024-2025 | Sancuso |
| Springworks Therapeutics, INC. | $26.86 | 2025 | Ogsiveo |
| Verity Pharmaceuticals INC. | $25.17 | 2024 | Trelstar |
| Catalyst Pharmaceuticals, INC. | $25.05 | 2023 | Firdapse |
| Lexicon Pharmaceuticals, INC. | $24.22 | 2019 | |
| Verastem, INC. | $23.86 | 2019 | |
| Shire North American Group INC | $23.18 | 2019 | |
| Novocure INC. | $22.36 | 2025 | Optune Lua (Novottf-200t) |
| Apellis Pharmaceuticals, INC. | $22.10 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.94 | 2019 | |
| Dendreon Pharmaceuticals LLC | $21.67 | 2019 | |
| Secura Bio, INC. | $21.07 | 2021 | |
| Spectrum Pharmaceuticals INC. | $19.84 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $19.76 | 2019 | |
| Jazz Pharmaceuticals INC. | $18.77 | 2025 | |
| Myovant Sciences INC. | $18.32 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $18.21 | 2019 | |
| Tesaro, INC. | $17.77 | 2019 | |
| Kyowa Kirin, INC. | $16.67 | 2019 | |
| Genentech, INC. | $14.05 | 2023 | Actemra |
| Dova Pharmaceuticals | $11.98 | 2019 | |
| Athena Bioscience, LLC | $5.71 | 2023 | Qdolo |
Drugs and devices associated with these payments
Kisqali $2,519Keytruda $806Sarclisa $746Ultomiris $688Reblozyl $474Enhertu $426Trodelvy $393Opdivo $345Imbruvica $312Welireg $310Cabometyx $283Libtayo $282Doptelet $272Adcetris $271Ninlaro $258Ibrance $222Ayvakit $222Brukinsa $220Scemblix $215Elrexfio $212Zejula $205Epkinly $204Nubeqa $203Braftovi $187Mektovi $184Vitrakvi $183Stivarga $183Opdualag $179Piqray $177Lorbrena $175Xalkori $175Lynparza $173Besremi $162Alunbrig $153Imfinzi $145Onivyde $138Padcev $137Krazati $136Xtandi $135Erleada $135Kimmtrak $130Tukysa $129Jakafi $128Bosulif $127Cellsearch $126Lenvima $119Inqovi $119Lonsurf $119Tivdak $115Fabhalta $110Talzenna $108Carvykti $108Inlyta $101Mi Cancer Seek $95.89Fotivda $92.18Bavencio $88.71Zoladex $88.24Jemperli $84.32Xpovio $84.21Rytelo $81.09Orserdu $78.25Venclexta $77.98Yescarta $74.15Tazverik $72.25Loqtorzi $72.13Monjuvi $72.00Udenyca $67.15Orgovyx $63.83Rybrevant $62.55Kyprolis $61.79Itovebi $61.47Lutathera $60.69Fruzaqla $58.69Keytruda Qlex $58.51Jaypirca $54.29Verzenio $54.29Retevmo $54.29Amtagvi $51.21Vyloy $49.07Somatuline Depot $47.71Phesgo $47.07Mekinist $45.96Beleodaq $45.51Nerlynx $43.96Blincyto $43.07Wayrilz $41.09Camcevi $40.76Injectafer $40.63Ojjaara $38.59Pomalyst $38.16Darzalex $35.15Tecvayli $35.15Tecentriq $30.69Pedmark $29.69Pyrukynd $28.66Sancuso $28.11Pluvicto $27.79Ogsiveo $26.86Trelstar $25.17Firdapse $25.05
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edna Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.